Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Angioli

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
Journal of the National Cancer Institute|April 21, 2005
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trialPierluigi Benedetti Panici, Angelo Maggioni, Neville Hacker, et al.
Gynecologic Oncology|October 9, 2016
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)Claudia Marchetti, Gabriella Ferrandina, Gennaro Cormio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 3, 2020
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancersNadeem R Abu-Rustum, Roberto Angioli, Arthur E Bailey, et al.
Journal of the National Cancer Institute|November 27, 2008
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trialPierluigi Benedetti Panici, Stefano Basile, Francesco Maneschi, et al.
Oncotarget|February 22, 2020
Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomasSalvatore Lopez, Emanuele Perrone, Stefania Bellone, et al.
Cancer Letters|July 3, 2018
Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1Leonel Maldonado, Mariana Brait, Evgeny Izumchenko, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 23, 2021
Factors predicting morbidity in surgically-staged high-risk endometrial cancer patientsGiorgio Bogani, Andrea Papadia, Alessandro Buda, et al.
Gynecologic Oncology|January 24, 2021
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional studyGiorgio Bogani, Andrea Papadia, Alessandro Buda, et al.
Gynecologic Oncology|June 20, 2022
Evaluating long-term outcomes of three approaches to retroperitoneal staging in endometrial cancerGiorgio Bogani, Violante Di Donato, Andrea Papadia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 21, 2023
Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: Perioperative and long-term results from a propensity-score based studyGiorgio Bogani, Violante Di Donato, Andrea Papadia, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Journal of the National Cancer Institute|April 21, 2005
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trialPierluigi Benedetti Panici, Angelo Maggioni, Neville Hacker, et al.
Gynecologic Oncology|October 9, 2016
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)Claudia Marchetti, Gabriella Ferrandina, Gennaro Cormio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 3, 2020
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancersNadeem R Abu-Rustum, Roberto Angioli, Arthur E Bailey, et al.
Journal of the National Cancer Institute|November 27, 2008
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trialPierluigi Benedetti Panici, Stefano Basile, Francesco Maneschi, et al.
Oncotarget|February 22, 2020
Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomasSalvatore Lopez, Emanuele Perrone, Stefania Bellone, et al.
Cancer Letters|July 3, 2018
Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1Leonel Maldonado, Mariana Brait, Evgeny Izumchenko, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 23, 2021
Factors predicting morbidity in surgically-staged high-risk endometrial cancer patientsGiorgio Bogani, Andrea Papadia, Alessandro Buda, et al.
Gynecologic Oncology|January 24, 2021
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional studyGiorgio Bogani, Andrea Papadia, Alessandro Buda, et al.
Gynecologic Oncology|June 20, 2022
Evaluating long-term outcomes of three approaches to retroperitoneal staging in endometrial cancerGiorgio Bogani, Violante Di Donato, Andrea Papadia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 21, 2023
Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: Perioperative and long-term results from a propensity-score based studyGiorgio Bogani, Violante Di Donato, Andrea Papadia, et al.
Pageof 25